Economic model of Alzheimer's disease that incorporates the uncertainty associated with measuring efficacy in clinical trials.
BackgroundClinical trials of Alzheimer's disease (AD) treatments are ongoing, and uncertainty about their efficacy is a key factor in their evaluation.ObjectiveThe objective of this study was to propose a new methodological approach for the economic evaluation of treatments to account for the uncertainty associated wit...